Showing 2111-2120 of 7802 results for "".
Why your dermatology practice isn’t ranking well on Google
https://practicaldermatology.com/topics/practice-management/why-your-dermatology-practice-isnt-ranking-well-on-google/19647/If your dermatology website isn’t ranking well on Google, there are hundreds of possible reasons why. However, in many cases the answer is quite simple. This Ekwa Marketing video explains some of the most common mistakes, and what to do about them.You Don’t Have Male
https://practicaldermatology.com/topics/practice-management/you-dont-have-male/23084/Male cosmetic patients are hard to come by. Here’s why!DermWireTV: AbbVie to Acquire Allergan, Duobrii Launches, SDPA at 25
https://practicaldermatology.com/topics/psoriasis/dermwiretv-abbvie-to-acquire-allergan-duobrii-launches-sdpa-at-25/19629/In a deal with an equity value of approximately $63 billion, AbbVie has agreed to acquire Allergan. The new company is positioned for new growth platforms and a diversified revenue base; the deal will be immediately accretive to earnings per share, AbbVie says. The Society of Dermatology Physician ABTL, Sciton Updates; Sun Gets PsO Real
https://practicaldermatology.com/topics/psoriasis/dermwire-tv-btl-sciton-updates-sun-gets-pso-real/19601/BTL rolls out a small Emsculpt applicator to treat arms, thighs and calves at ASLMS. Sciton introduces JOULE X. In conjunction with Sun Pharma, the Association for Applied and Therapeutic Humor is offering strategies to help psoriasis patients navigate emotional challenges and uncomfortable psoriasiThe Next Frontier: Device-Based Erectile Rejuvenation
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-next-frontier-device-based-erectile-rejuvenation/20828/Low-intensity cutaneous shockwave treatment represents a novel option for the treatment of vasculogenic ED.Private Equity in Dermatology: An Inside View
https://practicaldermatology.com/topics/practice-management/private-equity-in-dermatology-an-inside-view/18219/Private equity firms are turning their attention to the dermatology specialty. Why? How has the market changed and what may be on the horizon? An investment banker with knowledge of the field weighs in with an overview from him perspective.What Your Patients Need to Hear About Sunscreens
https://practicaldermatology.com/topics/general-topics/what-your-patients-need-to-hear-about-sunscreens/20432/You can't fight every misperception, but you can arm patients with essential facts.Myth Busters: Taking the Mystery Out of Online Directories
https://practicaldermatology.com/topics/practice-management/myth-busters-taking-the-mystery-out-of-online-directories/20552/If you aren't managing your directory listings, someone else is. Learn how to take control of your information or online presence.Lyme Disease Update
https://practicaldermatology.com/topics/general-topics/lyme-disease-update/20604/Exploring current thinking about Lyme Disease diagnosis and treatment.How To (and How Not To) Build Your Email List
https://practicaldermatology.com/topics/practice-management/how-to-and-how-not-to-build-your-email-list/20636/In an era when we are all inundated with excess email, how can you convince people to subscribe to your newsletter and announcements?